← Eichor
Condition: Hematological Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hematological Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Phase 1 · 1 location(s) · The Third Affiliated Hospital of Southern Medical University · NCT06758713Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation
NA · 1 location(s) · National Cancer Institute, Slovakia · NCT04691284A Multi-center Investigation of Family Health.
Phase N/A · 1 location(s) · Odense University Hospital · NCT06433349Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07321626Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Phase 1 · 4 location(s) · Cellenkos, Inc. · NCT05423691Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Tran
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05443425Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematologi
Phase N/A · 5 location(s) · Medical University Innsbruck · NCT06821880AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positiv
Phase 3 · 42 location(s) · University Hospital, Brest · NCT05198960In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07239323Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02464696Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Phase 2 · 1 location(s) · University of Nebraska · NCT06799195A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia:
Phase 1/Phase 2 · 2 location(s) · Jacqueline Garcia, MD · NCT07148180The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT06558253Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and
Phase 1/Phase 2 · 26 location(s) · Sellas Life Sciences Group · NCT04588922Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Inv
Phase 2 · 1 location(s) · Nantes University Hospital · NCT06541067Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
Phase 3 · 12 location(s) · Ottawa Hospital Research Institute · NCT04448184Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · 7 location(s) · Monash University · NCT05678621Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies
NA · 1 location(s) · Zhejiang Cancer Hospital · NCT07670949Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological M
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04195633Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05694806Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies
NA · 1 location(s) · Yesmine Amara · NCT07085065Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
Phase N/A · 1 location(s) · iOMEDICO AG · NCT06043011A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Phase 1/Phase 2 · 6 location(s) · Daiichi Sankyo · NCT07220616Germline Testing for Predisposition to Myeloid Malignancies
NA · 1 location(s) · Christopher Reilly · NCT07112287Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Phase 1 · 1 location(s) · Ronald Paquette · NCT05849207APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU
NA · 1 location(s) · Centre Hospitalier Régional Metz-Thionville · NCT05475600Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
NA · 1 location(s) · Washington University School of Medicine · NCT06689800Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT07162038B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide
Phase 1 · 1 location(s) · Mayo Clinic · NCT06191887Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hem
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06013423
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.